Tabletting, coating & ancillary equipment

M+W sells automation biz to ATS for $350m

M+W sells automation biz to ATS for $350m

By Dan Stanton

M+W says a lack of synergies with its engineering and construction business drove the decision to sell its automation divison to ATS for €255m ($348m).

Excipients, such as sorbitol, can affect bioavailability

US FDA issues new bioavailability guidelines

By Dan Stanton

The US FDA has published guidance of how sponsors should best document the bioavailability of products for investigational new drug applications (INDs) and new drug applications (NDAs).

Anti-addiction formulation of super-strong opioid unclear

Anti-addiction formulation of super-strong opioid unclear

By Fiona Barry

Addiction doctors have petitioned the US FDA to prevent Zohydro ER, the first single-entity hydrocodone painkiller, hitting the market this month citing its potential for abuse. Its maker, Zogenix, has been tight-lipped on whether the drug’s formulation...

Biopharma Companies Look to New Chromatography Columns

Biopharma Companies Look to New Chromatography Columns

By Zachary Brennan

Biopharma firms, particularly those producing insulin and five of its analogues, have another option in the market of sub-2 micron solid-core chromatography columns with a recent offering from Waters.

Follow us

Product Innovations